What’s Going On With Paycom Software Stock After Hours
Paycom Software Inc (NYSE:PAYC) stock is trading higher after hours on first-quarter earnings, which beat estimates and issued better than…
Why Tinder Parent Match Stock Is Trading Higher After Hours Today
Match Group Inc (NYSE: MTCH) stock is trading higher after-hours after it reported its earnings for the
SPDR Parent State Street Stock’s Recrod Plunge, AUM Fell 10% in Q1
State Street Corporation (NYSE: STT) reported Q1 revenues of $3.10 billion, up 1% Y/Y, missing the consensus estimate of $3.12 billion.…
Benzinga’s Talk of the Town: Top Social Trending Stories You Need To Know
What's trending on social media today:
Benzinga’s Talk of the Town: Top Social Trending Stories You Need To Know
Oscar Nominations: The Academy of Motion Picture Arts and Sciences revealed 2023 Academy Award nominees. 'Everything Everywhere All At Once,' 'Top Gun: Maverick,' 'Avatar; The Way Of Water,' 'Women Talking,' were some of the best picture nominations.
Benzinga’s Talk of the Town: Top Social Trending Stories You Need To Know
What's trending on Social Media today:
World Wrestling Entertainment Reviews Potential Sale, Return Of Former Chief Vince McMahon; Stock Soars
World Wrestling Entertainment, Inc (NYSE: WWE) shares are gaining in the after-hours session on the news report that the company could be exploring a potential sale.
Investors Cheer IBM’s Q3 Earnings Beat, Higher FY22 Revenue Expectation and $10B Free Cash Flow
IBM (NYSE: IBM) delivered third-quarter Non-GAAP EPS of $1.81, which bea
New Apple iPhone 14 Is Out, With New Emergency SOS Via Satellite. And No More Sim Trays
Apple Inc (NASDAQ: AAPL) introduced the much-awaited iPhone 14 and the iPhone Plus.
The 14 will have a 6.1-inch display, and the plus model will have a 6.7-inch display.
It sports the new A15 Bionic chip and all-day battery life.
EXCLUSIVE: Longeveron’s Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of Hypoplastic Left Heart Syndrome in Infants
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Longeveron Inc (NASDAQ: LGVN) Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS).